Novel lactylation-related signature to predict prognosis for pancreatic adenocarcinoma

Abstract

We constructed a novel lactylation-related prognostic signature to predict OS, immune status, and treatment response of patients with pancreatic adenocarcinoma, providing new strategic directions and antitumor immunotherapies.